Leptospira IgG ELISA Kit

The Leptospira IgG ELISA Kit is a qualitative enzyme-linked immunosorbent assay (ELISA) designed to detect IgG antibodies to Leptospira biflexa (serovar Patoc 1) in human serum or plasma. It is intended for the serological confirmation of suspected acute leptospirosis infections, particularly for laboratory diagnosis.

Leptospirosis is an acute infectious disease caused by pathogenic Leptospira bacteria. Clinical presentations range from mild flu-like symptoms to severe complications involving the liver and kidneys. Natural reservoirs include rodents and various domesticated animals, which shed the organism through their urine, contaminating water sources and soil. Human infections typically occur through direct contact with infected animals or exposure to contaminated environments (e.g., agricultural work, swimming in contaminated water).

The pathogen enters the human body through skin abrasions, mucous membranes, or the eyes. The incubation period is usually 10-12 days. IgG antibodies become detectable by day 6-10 of infection and peak within 3-4 weeks. Antibody levels gradually decline but may remain detectable for years. This kit provides a reliable and rapid method for detecting IgG antibodies, making it a valuable tool for the diagnosis of acute infections.

Leptospira IgG ELISA Kit

√  High Sensitivity: Capable of detecting low levels of Leptospira IgG antibodies.

√  High Specificity: Focused detection of Patoc 1 serovar reduces cross-reactivity.

√  User-Friendly: Simplified and standardized workflow for laboratory use.

√  Rapid Results: Efficient assay process delivers results in a short time.

√  Clear Readout: Strong colorimetric response enables visual or spectrophotometric reading.

√  Stable Storage: Reagents are stable at 2-8°C for reliable performance.

√  Quality Assurance: Prediluted positive and negative controls ensure consistent results.

√  Versatile Testing: Suitable for both single-sample and batch testing.

Leptospira IgG ELISA Kit

√  Clinical Laboratories: Diagnosis and monitoring of leptospirosis infections.

√  Public Health Centers: Screening populations in endemic and high-risk regions.

√  Agricultural and Veterinary Sectors: Monitoring high-risk workers (e.g., veterinarians, abattoir workers).

√  Epidemiological Research: Conducting prevalence studies and disease surveillance.

√  Water-Exposure Regions: Assessing infection risks among water workers and swimmers.

√  Remote Healthcare Facilities: Providing early diagnosis for resource-limited regions.

√  International Quarantine Services: Screening travelers and workers from high-risk areas.

√  Research Institutions: Supporting immunological and epidemiological studies on leptospirosis.